- Home
- ORRF vs JANX Comparison
ORRF vs JANX Comparison
Compare ORRF & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORRF | JANX |
|---|---|---|
| Founded | 1919 | 2017 |
| Country | United States | United States |
| Employees | 652 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.8M | 790.3M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ORRF | JANX |
|---|---|---|
| Price | $36.54 | $14.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | $42.00 | ★ $48.73 |
| AVG Volume (30 Days) | 104.7K | ★ 1.0M |
| Earning Date | 04-21-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | ★ 182.43 | N/A |
| EPS | ★ 4.18 | N/A |
| Revenue | ★ $37,144,000.00 | $10,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.15 | N/A |
| P/E Ratio | $8.75 | ★ N/A |
| Revenue Growth | ★ 36.00 | N/A |
| 52 Week Low | $28.55 | $12.12 |
| 52 Week High | $40.72 | $35.34 |
Technical Indicators
Market Signals| Indicator | ORRF | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 46.35 | 53.98 |
| Support Level | $32.67 | $13.10 |
| Resistance Level | $38.12 | $15.49 |
| Average True Range (ATR) | 1.12 | 0.61 |
| MACD | -0.22 | -0.00 |
| Stochastic Oscillator | 24.82 | 29.53 |
Price Performance
Historical ComparisonAbout ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.